Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ro 24-7429 in HIV-Related Kaposi's Sarcoma
NCT00002314Phase 2Completed
- Sponsor
- Roche
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Tivirapine in Kaposi sarcoma (KS), sponsored by Roche. Primary endpoint: Tumor Growth Response. Status: completed.
02
Drugs
Tivirapine
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00002314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002314.